We are live on ! Find out more
TMCI icon

Treace Medical Concepts

135 hedge funds and large institutions have $278M invested in Treace Medical Concepts in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

736% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $145K

2% more funds holding

Funds holding: 133 → 135 (+2)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

3.82% less ownership

Funds ownership: 63.7% → 59.88% (-3.8%)

37% less capital inflows, than outflows

Capital inflows: $24.3M | Capital outflows: $38.9M

Holders
135
Holders Change
+2
Holders Change %
+1.5%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
42
Reduced
46
Closed
22
Calls
$1.21​M
Puts
$145​K
Net Calls
+$1.07​M
Net Calls Change
+$1.25​M

TMCI Hedge Fund Activity: Q4 2024 in Review

135 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2024, worth a combined $278M — up 21% from $230M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of TMCI and 20 opened new positions — a net loss of 2 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was UBS Group, adding an estimated $5.97M. The largest seller was Morgan Stanley, cutting an estimated $7.58M.

  • 135 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2024, up from 133 in Q3 2024.
  • Funds reported $278M of Treace Medical Concepts stock for Q4 2024, up 21% quarter-over-quarter.
  • 20 funds opened new Treace Medical Concepts positions in Q4 2024 and 22 closed out, a net change of -2 holders.
  • The largest Treace Medical Concepts buyer in Q4 2024 was UBS Group, an estimated $5.97M added.
  • The largest Treace Medical Concepts seller in Q4 2024 was Morgan Stanley, an estimated $7.58M sold.

Based on aggregated 13F filings for Q4 2024.